AbbVie secured over 130 patents around Humira, creating a thicket that kept biosimilar competitors out of the U.S
Retatrutide Regulatory Status As of June 2026, retatrutide is not approved by the FDA, the EMA, or any other regulatory agency
This selectivity means fewer side effects compared to older GH secretagogues like GHRP-6 (which increases appetite) or GHRP-2 (which can elevate cortisol)
Modern lifestyle factors such as poor dietary habits, psychological stress, polypharmacy, and exposure to environmental toxins frequently disrupt microbial balance and lead to dysbiosis, a state increasingly linked to numerous systemic conditions, including endocrine disorders (Ma et al., 2022
This could be the perfect opportunity to build lean muscle